Evaluation of waning of SARS-CoV-2 vaccine–induced immunity: a systematic review and meta-analysis
Importance Estimates of the rate of waning of vaccine effectiveness (VE) against COVID-19
are key to assess population levels of protection and future needs for booster doses to face …
are key to assess population levels of protection and future needs for booster doses to face …
Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic
R Solante, C Alvarez-Moreno, E Burhan… - Expert review of …, 2023 - Taylor & Francis
Introduction COVID-19 vaccines have been highly effective in reducing morbidity and
mortality during the pandemic. However, the emergence of the Omicron variant and …
mortality during the pandemic. However, the emergence of the Omicron variant and …
[HTML][HTML] Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence …
Background Synthesising evidence on the long-term vaccine effectiveness of COVID-19
vaccines (BNT162b2 [Pfizer–BioNTech], mRNA-1273 [Moderna], ChAdOx1 nCoV-19 …
vaccines (BNT162b2 [Pfizer–BioNTech], mRNA-1273 [Moderna], ChAdOx1 nCoV-19 …
[HTML][HTML] SARS-CoV-2 infection following booster vaccination: illness and symptom profile in a prospective, observational community-based case-control study
Background Booster COVID-19 vaccines have shown efficacy in clinical trials and
effectiveness in real-world data against symptomatic and severe illness. However, some …
effectiveness in real-world data against symptomatic and severe illness. However, some …
Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022
B de Gier, L van Asten, TM Boere, A van Roon… - Vaccine, 2023 - Elsevier
Background We aimed to estimate vaccine effectiveness (VE) against COVID-19 mortality,
and to explore whether an increased risk of non-COVID-19 mortality exists in the weeks …
and to explore whether an increased risk of non-COVID-19 mortality exists in the weeks …
Long-term real-world protection afforded by third mRNA doses against symptomatic severe acute respiratory syndrome coronavirus 2 infections, coronavirus disease …
Background Literature on long-term real-world vaccine effectiveness of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) booster vaccines (up to and beyond 360 …
respiratory syndrome coronavirus 2 (SARS-CoV-2) booster vaccines (up to and beyond 360 …
Observational methods for COVID-19 vaccine effectiveness research: an empirical evaluation and target trial emulation
M Català, E Burn, T Rathod-Mistry, J Xie… - International Journal …, 2024 - academic.oup.com
Background There are scarce data on best practices to control for confounding in
observational studies assessing vaccine effectiveness to prevent COVID-19. We compared …
observational studies assessing vaccine effectiveness to prevent COVID-19. We compared …
[HTML][HTML] The vaccine efficacy against the SARS-CoV-2 omicron: a systemic review and meta-analysis
Y Zou, D Huang, Q Jiang, Y Guo, C Chen - Frontiers in Public Health, 2022 - frontiersin.org
Background COVID-19 is a respiratory illness caused by SARS-CoV-2. The most recent
variant is Omicron (line B. 1.1. 529), which was first identified in South Africa in November …
variant is Omicron (line B. 1.1. 529), which was first identified in South Africa in November …
[HTML][HTML] Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people
Background Some studies have shown that the incidence of type 2 diabetes increases after
a diagnosis of COVID-19, although the evidence is not conclusive. However, the effects of …
a diagnosis of COVID-19, although the evidence is not conclusive. However, the effects of …
[HTML][HTML] Comparative effectiveness of two-and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked …
Background Kidney disease is a key risk factor for COVID-19-related mortality and
suboptimal vaccine response. Optimising vaccination strategies is essential to reduce the …
suboptimal vaccine response. Optimising vaccination strategies is essential to reduce the …